Summary
Specialist inspectors have identified cases of Salbutamol inhaler overprescribing of up to six inhalers per prescription by online prescribers. This article explores the risks of prescribing high volumes of Salbutamol inhalers. It highlights the need for ongoing patient monitoring, counselling advice, inhaler device choices and discuss the clinical considerations when continuing treatment.
General Pharmaceutical Council patient safety spotlight: the risks of overprescribing Salbutamol inhalers for asthma (31 May 2022)
https://www.pharmacyregulation.org/regulate/article/patient-safety-spotlight-risks-overprescribing-salbutamol-inhalers-asthma
0
reactions so far
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now